$13.66+0.08 (+0.59%)
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States.
Aveanna Healthcare Holdings Inc. in the Healthcare sector is trading at $13.66 with a market capitalization of $1.6B. Wall Street consensus targets $13.90 (10 analysts), implying a +1.8% move over the next 12 months. The stock is currently near its 52-week high of $14.00, remaining 62.2% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $647.91M↓ | $662.48M↑ | $621.94M↑ | $589.55M↑ | $559.22M |
| Gross Profit | $205.43M↓ | $213.30M↑ | $202.82M↓ | $210.80M↑ | $183.56M |
| Operating Income | $72.44M↓ | $72.53M↑ | $52.41M↓ | $83.43M↑ | $51.91M |
| Net Income | $41.65M↓ | $178.75M↑ | $14.06M↓ | $27.02M↑ | $5.19M |
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the ...

Why Aveanna Healthcare Holdings (AVAH) Is On Value Investors’ Radar Recent research flagged Aveanna Healthcare Holdings (AVAH) as potentially undervalued, with valuation ratios that compare favorably with industry peers and an earnings outlook that has attracted fresh attention from value focused investors. This combination of relatively lower P/E, P/S, and P/CF metrics, together with that earnings view, has turned a spotlight on how the market is currently pricing Aveanna Healthcare and what...

The updated analyst work on Aveanna Healthcare Holdings centers on a higher fair value estimate, moving from US$9.95 to US$13.90. This points to a meaningfully higher price target range in the low to mid teens. Analysts tie this shift to the Q2 report, the refreshed long term framework through 2027, and to how reimbursement trends and state rate decisions could influence the stock over time. Read on to see what is driving the evolving story around Aveanna Healthcare Holdings and how you can...

Aveanna Healthcare Holdings has seen a very large gain over the past three years, yet current checks still frame the stock as leaning cheap rather than fully priced in. After such a strong move, investors are now weighing how much of the home care growth story is already reflected in the share price. The stock is up by a very large multiple over the past three years, which puts extra focus on whether that past return can be justified by the company’s fundamentals. RBC’s view is that secular...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.